In 2007 was created CDI Bioscience, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Madison. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Novo Holdings, New Medical Technologies, Manulife Financial. In the next rounds fund is usually obtained by Vulcan Capital, Novo Holdings, HealthCap.
The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2013. The top activity for fund was in 2001. The fund is constantly included in less than 2 deals per year.
Among the most successful fund investment fields, there are Biotechnology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline PTC Therapeutics
This organization was formed by Victor Levenson, Vitaliy Gavrilyuk.
Fund Name | Location |
4BIO Capital | England, London, United Kingdom |
Chengdu Caic Electronics Co., Ltd | Chengdu, China, Sichuan |
Creador | Kuala Lumpur, Malaysia |
Enlightened Capital | - |
Eudemian Ventures | California, San Francisco, United States |
Future Fund | Australia, Melbourne, Victoria |
Groupe SEB | Carros, France, Provence-Alpes-Cote d'Azur |
Haitao Capital | China, Shanghai |
Jolimont Capital | Australia, Melbourne, Victoria |
MLS Players Association | Bethesda, Maryland, United States |
Nexus Capital Partners | Buenaventura, Colombia, Valle del Cauca |
OQAL Ltd | - |
Palladin Consumer Retail Partners | Boston, Massachusetts, United States |
Rodman & Renshaw | New York, New York, United States |
RONAholdings | California, San Francisco, United States |
Segittur | Community of Madrid, Madrid, Spain |
Taishan Invest AG | Beijing, Beijing, China |
TSI Holdings | Chiyoda, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.